Policy | March 06, 2024
Dr. Mandaviya inaugurates Sadhana Nitro Chem’s Para Amino Phenol bulk drug plant
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
Subscribe To Our Newsletter & Stay Updated
